Regulus: 2Q Earnings Snapshot
SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $13.8 million in its second quarter.
The San Diego-based company said it had a loss of 13 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The biopharmaceutical company posted revenue of $18,000 in the period.
In the final minutes of trading on Thursday, the company’s shares hit 22 cents. A year ago, they were trading at 90 cents.